If you need more lookups,
subscriptions start at $34 USD/month.
Abdel Halim Location
United States
Abdel Halim Work
2024 -now CEO and CSO @
2011 -now Key Opinion Leader @ KOL/Advisor
2022 -2024 CSO and EVP @
2019 -2022 VP, Biomarkers and Companion Diagnostics @
2014 -2018 VP Translational Medicine, Biomarkers and Diagnostics @
2008 -2013 Global Head, Clinical Biomarkers @
2007 -2008 Director of Laboratories @ LipoScience
2003 -2007 Assistant Director and Technical Manager of Laboratories @
1999 -2003 Assistant Professor and Associate Director of the Surgical Immunology Lab @
1998 -1999 Research Associate @
1996 -1997 Postdoctoral Fellow @ Tulane Medical Center
Abdel Halim Education
Bonn University (Germany), Cairo University (Egypt)
PhD (Biochemistry (Molecular Biology and Tumor Biomarkers))
Abdel Halim Skills
Clinical Trials
Pharmaceutical Industry
Assay Development
Biotechnology
Biomarkers
Precision medicine
Companion diagnostics
Translational medicine
Clinical laboratory
IVD
Clinical development
Oncology
Cardiovascular
Abdel Halim Summary
Abdel Halim, based in United States, is currently a CEO and CSO at Wren Laboratories. Abdel Halim brings experience from previous roles at KOL/Advisor, Acutis Diagnostics, TAIHO ONCOLOGY INC and Celldex Therapeutics. Abdel Halim holds a PhD in Biochemistry (Molecular Biology and Tumor Biomarkers) @ Bonn University (Germany), Cairo University (Egypt). With a robust skill set that includes Clinical Trials, Pharmaceutical Industry, Assay Development, Biotechnology, Biomarkers and more. Abdel Halim has 3 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Abdel Halim?
Find contact details for 700 million professionals.